Search results
Emcure Pharma closes 3% higher after making strong market debut; should you buy the stock now? |...
Livemint· 4 days agoEmcure Pharma’s IPO saw strong investor interest, with oversubscription rates of 67.87 times....
Top Stock Recommendations: Dharmesh Shah of ICICI Securities suggests buying BEL, and LTIMindtree on...
Livemint· 15 hours agoStock Market News: The market-leading Tata Consultancy Services' earnings indicated early...
Week Ahead: Q1 Results, Budget updates, global cues among key market triggers this week; Nifty eyes...
Livemint· 20 hours agoIndian stock market continued its record bull run picked up since June-end led by return of foreign...
Trading activity to hinge on Q1 results, global trends in holiday-shortened week: Analysts
Financial Express· 15 hours agoThe domestic WPI inflation data for June -- scheduled to be announced on Monday -- will also...
Stock Market Update: Inflation, Q1 Results, Global Trends Key Drivers In Holiday-shortened Week -...
News18· 14 hours agoThe combined market valuation of seven of the top-10 most valued firms jumped Rs 1,72,225.62 crore...
Q1 results, global trends to influence trading activity in mkts in holiday-shortened week: Analysts
CNBC Awaaz· 1 day ago"Q1 earnings will be a key focus this week as numerous companies, including heavyweights Infosys,...
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Business Standard India· 5 days agoEmcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a...
Q1 results to influence trading in mkts in holiday-shortened week: Analysts
Business Standard India· 1 day agoQuarterly earnings from several blue-chip firms, including Infosys and Reliance Industries, global...
Factors that will guide the markets this week
rediff.com· 9 hours agoAs the results season kicks in, the quarterly earnings numbers of several blue-chip firms -- such as Infosys and Reliance Industries -- along with global trends and trading activity of foreign ...
Emcure Pharma IPO: Namita Thapar-backed issue may debut with 30% gains amid high investor interest -...
CNBC TV18· 6 days agoThe grey market premium (GMP) of Emcure Pharmaceuticals has jumped sharply following the closure of...